Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective Study.

Kano S, Kawakita D, Honma Y, Takahashi H, Hanazawa T, Tsukahara K, Fujii S, Okami K, Yamazaki K, Ueki Y, Saito Y, Ozawa H, Imaizumi S, Arai T, Iwaki S, Hanyu K, Yamauchi M, Tanaka R, Yamamura K, Sekimizu M, Fushimi C, Matsuki T, Utsumi Y, Nakaguro M, Nagao T, Tada Y, Multi‐institutional Joint SDC Study Group in Japan

Open source

DOI
10.1002/hed.70416
Published
2026 Jul 31
Container
Head & neck
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hed.70416,
  title = {Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective Study.},
  author = {Kano S and Kawakita D and Honma Y and Takahashi H and Hanazawa T and Tsukahara K and Fujii S and Okami K and Yamazaki K and Ueki Y and Saito Y and Ozawa H and Imaizumi S and Arai T and Iwaki S and Hanyu K and Yamauchi M and Tanaka R and Yamamura K and Sekimizu M and Fushimi C and Matsuki T and Utsumi Y and Nakaguro M and Nagao T and Tada Y and Multi‐institutional Joint SDC Study Group in Japan},
  year = {2026},
  journal = {Head \& neck},
  doi = {10.1002/hed.70416},
  url = {https://doi.org/10.1002/hed.70416}
}

RIS

TY  - JOUR
TI  - Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective Study.
AU  - Kano S
AU  - Kawakita D
AU  - Honma Y
AU  - Takahashi H
AU  - Hanazawa T
AU  - Tsukahara K
AU  - Fujii S
AU  - Okami K
AU  - Yamazaki K
AU  - Ueki Y
AU  - Saito Y
AU  - Ozawa H
AU  - Imaizumi S
AU  - Arai T
AU  - Iwaki S
AU  - Hanyu K
AU  - Yamauchi M
AU  - Tanaka R
AU  - Yamamura K
AU  - Sekimizu M
AU  - Fushimi C
AU  - Matsuki T
AU  - Utsumi Y
AU  - Nakaguro M
AU  - Nagao T
AU  - Tada Y
AU  - Multi‐institutional Joint SDC Study Group in Japan
PY  - 2026
JO  - Head & neck
DO  - 10.1002/hed.70416
UR  - https://doi.org/10.1002/hed.70416
ER  - 

APA

S, K., D, K., Y, H., H, T., T, H., K, T., S, F., K, O., K, Y., Y, U., Y, S., H, O., S, I., T, A., S, I., K, H., M, Y., R, T., K, Y., M, S., C, F., T, M., Y, U., M, N., T, N., Y, T., & Japan, M. J. S. S. G. I. (2026). Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective Study.. Head & neck. https://doi.org/10.1002/hed.70416

Source records